Laparoscopy
144
7
9
89
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Research Maturity
89 completed trials (62% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.4%
2 terminated out of 144 trials
97.8%
+11.2% vs benchmark
12%
17 trials in Phase 3/4
10%
9 of 89 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 89 completed trials
Clinical Trials (144)
Spinal Morphine and Atropine Added to General Anaesthesia for Nausea and Pain After Abdominal Laparoscopy
The Turbine-based CO2 Insufflator Pediatric Feasibility Study
Laparoscopic Sclerotherapy for the Management of Ovarian Endometriomas
Paired Comparison of SVV and PVI Accuracy
Post-market Clinical Follow-up Study of Reusable Clip Applier Cartridge Devices for LAParoscopic Surgery
The Role of Expectations on Complaints and Well-being After Endometriosis Surgery in Women
ICG for Visualization of the Ureters in DIE
Oliceridine on Postoperative Nausea and Vomiting in Gynecological Laparoscopic Surgery
Deep Rectus Sheath (DRS) Block in Abdominal Surgery
Transabdominal Preperitoneal Inguinal Hernia Repair
Tolerance of the vNOTES Surgical Technique in Total Hysterectomy for Benign Lesion. Clinical Trial of Non-inferiority Compared to the Laparoscopic Technique.
Effects of Insufflated Gas on Core Temperature and Post-operative Pain During Laparoscopic Surgery
Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery?
Efficacy of In-bag Morcellation
Effects of Different Peep Applications on Tissue Oxygenation, Respiratory Mechanics and Postoperative Pulmonary Complications in Laparoscopic Hysterectomy Operations
Low Versus Standard Pressure Pneumoperitoneum on Shoulder Tip Pain
Surgeon Perception of Gastric Decompression at Time of Gynecologic Laparoscopy
Post-discharge Monitoring Initiative on Outcomes of Post-surgical Patients
Virtual Reality Training for Laparoscopic Cholecystectomy
Triple Therapy of Dexamethasone, Palonosetron, and Fosaprepitant As PONV Prevention